课题基金 / 基金详情

IL-1β regulation of Zika-mediated adverse perinatal outcomes

IL-1β regulation of Zika-mediated adverse perinatal outcomes
IL-1β 调节 Zika 介导的不良围产期结局
批准号:
10189676
负责人:
IRINA BURD
金额:
$59.74万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-21 至 2023-06-30

项目摘要

项目成果

IRINA BURD的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
SUMMARY Zika virus (ZIKV) infection of pregnant females results in congenital infection of offspring and long-term developmental birth defects. Using an immunocompetent mouse model that we developed (published in Nature Communications), we have shown that intrauterine infection with either African, American, or Asian strains of ZIKV during early, but not late, pregnancy causes infection of the placenta and fetuses, placental inflammation, neonatal cortical thinning, and short-term neurologic deficits in offspring. More recently, we have demonstrated that placental IL-1β concentrations are elevated in ZIKV-infected dams, and we can reverse the ZIKV-associated short-term neurobehavioral sequelae in offspring by blocking IL-1 receptor signaling during the infection. We hypothesize that placental inflammation following intrauterine ZIKV infection causes perinatal neurological injury, which can then be reversed by targeting maternal IL-1β signaling. While most ZIKV interventions focus on antivirals and vaccines to limit perinatal ZIKV infection, to date no studies have considered the role of maternal and placental inflammation as a mechanism mediating long-term adverse perinatal outcomes following ZIKV infection. Specific Aim 1 will assess the mechanisms mediating elevated IL- 1β signaling in the placenta at different gestational ages following ZIKV infection, the long-term downstream effects of the placental immunopathology and placental IL-1β signaling, and whether these effects are sex- specific. In particular, Aim 1 will determine how placental inflammasome activation, IL-1β release, or engagement of the IL-1 receptor lead to adverse perinatal outcomes. Specific Aim 2 will examine the importance of maternal as opposed to fetal IL-1β signaling in the pathogenesis of perinatal brain injury following ZIKV infection. Using embryo transfer of IL-1β signaling deficient and wild type mouse strains, Aim 2 will assess whether IL-1β activity of maternal origin is critical for sex-specific fetal brain injury. Our novel translational research proposal, utilizing a ZIKV model that we developed, will have a significant impact on perinatal medicine as it will lead to a better understanding of the role of placental inflammation in the pathogenesis of fetal congenital diseases caused by infection or other inflammatory states during pregnancy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Placental Serum Amyloid A as a Therapeutic Target to Prevent Preterm Birth and Prematurity Related Morbidity
IL-1B regulation of Zika-Mediated adverse perinatal outcomes
Nanomedicine-based approach for characterizing the epigenome in prevention of inflammation-induced preterm birth.
  • 批准号:
    10586624
  • 项目类别:
  • 资助金额:
    $62.44万
  • 财政年份:
    2022
  • 负责人:
    IRINA BURD
  • 依托单位:
Nanomedicine approaches for prevention of inflammation-induced preterm birth
  • 批准号:
    10392489
  • 项目类别:
  • 资助金额:
    $62.97万
  • 财政年份:
    2021
  • 负责人:
    IRINA BURD
  • 依托单位:
海外基金